Mitoxantrone is a cancer (antineoplastic) medication. Mitoxantrone interferes with the growth of cancer cells and slows their growth and spread in the body. Mitoxantrone also affects the immune system.
Mitoxantrone is used in the treatment of prostate cancer; acute nonlymphocytic leukemia (ANLL) including myelogenous, promyelocytic, monocytic, and erythroid acute leukemias; and multiple sclerosis.
Mitoxantrone may also be used for purposes other than those listed in this medication guide.
Before taking mitoxantrone, tell your doctor if you have
You may not be able to take mitoxantrone, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.
Mitoxantrone is in the FDA pregnancy category D. This means that mitoxantrone is known to cause birth defects in an unborn baby. Do not take mitoxantrone without first talking to your doctor if you are pregnant or could become pregnant during treatment. Contraceptive measures are recommended during treatment with mitoxantrone.
Mitoxantrone passes into breast milk and may harm a nursing baby. Do not take mitoxantrone without first talking to your doctor if you are breast-feeding a baby.
Mitoxantrone can lower the activity of the immune system making you susceptible to infections. Avoid contact with people who have colds, the flu, or other contagious illnesses and do not receive vaccines that contain live strains of a virus (e.g., live oral polio vaccine) during treatment with mitoxantrone. In addition, avoid contact with individuals who have recently been vaccinated with a live vaccine. There is a chance that the virus can be passed on to you.
If for any reason an overdose of mitoxantrone is suspected, seek emergency medical attention or contact your healthcare provider immediately.
Symptoms of a mitoxantrone overdose tend to be similar to side effects caused by the medication, although often more severe.
Contact your doctor if you miss a dose of mitoxantrone injection.
Mitoxantrone may damage your heart at any time during therapy or months to years after therapy ends. Heart damage caused by mitoxantrone can be serious and may cause death. Your doctor will perform certain tests to see that your heart is working normally before you start to take mitoxantrone. Your doctor will repeat these heart tests before you receive each additional dose. Your doctor will also perform these tests if you have any symptoms of heart problems. Because the risk to your heart may depend on the total amount of mitoxantrone given, your doctor will limit the number of doses you get. Most patients will reach this limit after about 8 to 12 doses given over 2 to 3 years. After you have reached your limit, you should not receive any additional mitoxantrone. You and your doctor should both keep track of how much mitoxantrone you get.
In some cases, the use of mitoxantrone has been associated with the development of secondary acute leukemia. Talk to your doctor about the risks and benefits of this medication.
If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:
Other less serious side effects may be more likely to occur. Talk to your doctor if you experience:
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.
Do not take mitoxantrone without first talking to your doctor if you have had previous treatment with the cancer drugs daunorubicin (Cerubidine, Daunoxome) or doxorubicin (Adriamycin, Rubex, Doxil). You may not be able to take mitoxantrone, or you may require a dosage adjustment or special monitoring during treatment.
Drugs other than those listed here may also interact with mitoxantrone. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including vitamins, minerals, and herbal products, during treatment with mitoxantrone.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04